Evidence map›Paper›PMID 34309806›Full record

ArticleClinical pharmacokinetics2022

Metformin Transport Rates Between Plasma and Red Blood Cells in Humans.

Janis Kurlovics, Darta Maija Zake, Linda Zaharenko, Kristaps Berzins, Janis Klovins, Egils Stalidzans

Open access · hybridAbstract read
In one paragraph

Article in Clinical pharmacokinetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 7 citations in OpenAlex.

  1. medRxiv : the preprint server for health sciences · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Janis KurlovicsComputational Systems Biology Group, Institute of Microbiology and Biotechnology, University of Latvia, Riga, Latvia. janis.kurlovics@lu.lv.ORCID 0000-0002-4418-8055
Darta Maija ZakeComputational Systems Biology Group, Institute of Microbiology and Biotechnology, University of Latvia, Riga, Latvia.
Linda ZaharenkoLatvian Biomedical Research and Study Centre, Riga, Latvia.
Kristaps BerzinsComputational Systems Biology Group, Institute of Microbiology and Biotechnology, University of Latvia, Riga, Latvia.
Janis KlovinsLatvian Biomedical Research and Study Centre, Riga, Latvia.
Egils StalidzansComputational Systems Biology Group, Institute of Microbiology and Biotechnology, University of Latvia, Riga, Latvia.
Latvian Biomedical Research and Study Centre · LVUniversity of Helsinki · FIUniversity of Latvia · LV

Funding

h2020 excellent science 857572Latvijas Zinātnes Padome LZP-2018/2-0088
6 · The paper itself

Abstract

backgroundMetformin has been used for the treatment of type 2 diabetes for over 60 years; however, its mechanism of pharmacological action is not fully clear. Different hypotheses exist regarding metformin distribution and redistribution mechanisms between plasma and erythrocytes/red blood cells (RBCs).

objectiveWe aimed to test the hypothesis that the metformin distribution between plasma and RBC occurs via concentration difference-driven passive transport and estimated transport rate coefficient values based on metformin concentration time series in plasma and RBCs from in vivo studies.

methodsAn ordinary differential equation (ODE) system with two compartments was used to describe diffusion-based passive transport between plasma and RBCs. Metformin concentration time series in plasma and RBCs of 35 individuals were used for metformin transport parametrization. Plasma concentration has been approximated by biexponential decline.

resultsA single passive transport coefficient, k = 0.044 ± 0.014 (h

conclusionsOur research suggests that passive transport can explain metformin distribution dynamics between plasma and RBCs because transport speed is proportional to the metformin concentration difference and independent of the transport direction. Concentration difference-driven passive transport can explain the mechanism of faster metformin distribution to RBCs the first few hours after administration, and faster release and domination of the redistribution transport rate after metformin concentration in plasma becomes smaller than in RBCs.

Indexed as

Diabetes Mellitus, Type 2MetforminBiological TransportErythrocytesHumansTime FactorsMetformin

Identifiers

PMID34309806
PMCPMC8761711
OpenAlexW3183658334

What OpenQuestion holds

Texttitle and abstract
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.